Sort
25,944 grants matching “neurodegeneration”
Cryptic exon splicing mediated by TDP-43 loss of function as the underlying mechanism of pathogenesis in FTLD-TDP
$786,257Aaron D. Gitler · Stanford University · U54 · FY2023 · NS
Mechanisms of Prion Protein Toxicity
$786,131David A Harris · Boston University Medical Campus · R01 · FY2021 · NS
Clinical Core
$785,944Christopher H Van Dyck · Yale University · P30 · FY2021 · AG
Identification of small molecules for neurological complications of HIV and substance abuse comorbidity
$785,874Pietro P Sanna · Scripps Research Institute, The · R01 · FY2019 · DA
Genetic Drivers of Resilience to Alzheimer's Disease
$785,860Timothy J Hohman · Vanderbilt University Medical Center · R01 · FY2019 · AG
Disease pathways in the population determined by amyloid, tau, and neurodegeneration imaging biomarkers
$785,776Clifford Jack · Mayo Clinic Rochester · R37 · FY2024 · AG
Identifying Factors Regulating Medium Spiny Neuron Differentiation or Maintenance as Therapeutic Targets for Huntington's Disease using Induced Pluripotent Stem Cells
$785,686Lisa M. Ellerby · Buck Institute For Research On Aging · R01 · FY2025 · NS
Alzheimer's Abeta, Tau, Apolipoproteins and Blood-brain barrier
$785,580Berislav V Zlokovic · University Of Southern California · R01 · FY2022 · NS
Pharmacokinetic/toxicology & in vivo efficacy of potential AD therapeutic agents
$785,438Sam Khatami · Neuronautics, Inc. · R44 · FY2007 · AG
Ubiquitin Proteasome System and Molecular Signatures of Alzheimer's Disease
$785,292Tauseef R. Butt · Lifesensors, Inc. · R44 · FY2020 · AG
Small molecule mitochondria-targeted therapeutics for AD
$785,056Eugenia Trushina · Mayo Clinic Rochester · UG3 · FY2021 · NS
Biological Aging Contributions to Molecular Pathology and Neurodegeneration
$785,030Corey T McMillan · University Of Pennsylvania · R01 · FY2020 · AG
Design And Development Of Experimental Therapeutics
$784,982Nigel H. Greig · National Institute On Aging · ZIA · FY2010 · AG
Regulation of HIV latency by microglial-neuronal interactions
$784,868Jonathan Karn · Case Western Reserve University · R01 · FY2023 · DA
Comprehensive and Cell Type-Specific Proteogenomic Profiling of Aberrant and Mis-Processed Proteins in Alzheimer's Disease and Tauopathy Models
$784,596Nikolai Slavov · Northeastern University · R01 · FY2025 · AG
Mechanisms of Prion Protein Toxicity
$784,573David A Harris · Boston University Medical Campus · R01 · FY2022 · NS
Neurofunctional Mechanisms of Changes in Cognition and Motor Function in Aging with HIV and Parkinson's Disease
$784,552Tilman Schulte · Sri International · R01 · FY2025 · AG
Longitudinal Multi-modal Imaging in Progressive Supranuclear Palsy Syndromes
$784,471Jennifer Louise Whitwell · Mayo Clinic Rochester · R01 · FY2023 · NS
Primary Progressive Aphasia: Cognition, Anatomy and Progression
$784,402Maria Luisa Gorno Tempini · University Of California, San Francisco · R01 · FY2019 · NS
Vascular Mechanisms of Dementia: Cell-Type Specific Therapeutic and Imaging Strategies
$784,245Jaime Grutzendler · Yale University · R01 · FY2025 · NS
Biological Aging Contributions to Molecular Pathology and Neurodegeneration
$784,211Corey T McMillan · University Of Pennsylvania · R01 · FY2019 · AG
Cognitive Computing of Alzheimer's Disease Genes and Risk
$783,998Olivier Lichtarge · Baylor College Of Medicine · U01 · FY2025 · AG
The role of N6-methyladenosine modified RNA in Alzheimer's disease
$783,699Benjamin L Wolozin · Boston University Medical Campus · R01 · FY2024 · AG
A ketogenic longevity diet for resistance to age-related functional decline and Alzheimer's disease
$783,430Gino A Cortopassi · University Of California At Davis · R56 · FY2018 · AG
An Integrative Computational Multimodal approach to disentangle Pathophysiologic Heterogeneity of age-related White Matter Hyperintensities
$783,284Chia-Ling Phuah · St. Joseph'S Hospital And Medical Center · R01 · FY2025 · AG